Recombinant human C1 esterase inhibitor treatment for hereditary angioedema attacks in children

BACKGROUND: Attacks of hereditary angioedema (HAE) due to C1 esterase inhibitor deficiency (C1‐INH‐HAE) usually begin during childhood or adolescence. However, limited data are available regarding indications and modalities of treatment of children. This study evaluated recombinant human C1‐INH (rhC...

Descripción completa

Detalles Bibliográficos
Autores principales: Reshef, Avner, Grivcheva‐Panovska, Vesna, Kessel, Aharon, Kivity, Shmuel, Klimaszewska‐Rembiasz, Maria, Moldovan, Dumitru, Farkas, Henriette, Gutova, Vaclava, Fritz, Stephen, Relan, Anurag, Giannetti, Bruno, Magerl, Markus
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6851822/
https://www.ncbi.nlm.nih.gov/pubmed/30993784
http://dx.doi.org/10.1111/pai.13065

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6851822/
https://www.ncbi.nlm.nih.gov/pubmed/30993784
http://dx.doi.org/10.1111/pai.13065

Ejemplares similares